Sofinnova Investments, Inc. Axsome Therapeutics, Inc. Transaction History

Sofinnova Investments, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$58.41 - $90.35 $3.41 Million - $5.27 Million	58,346 Added 48.26%	179,242 $12.9 Million
Q1 2023 May 11, 2023	BUY	$58.39 - $75.0 $7.06 Million - $9.07 Million	120,896 New	120,896 $7.46 Million
Q3 2020 Nov 13, 2020	SELL	$68.34 - $85.84 $5.94 Million - $7.47 Million	-86,978 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$49.87 - $98.69 $688,954 - $1.36 Million	13,815 Added 18.88%	86,978 $7.16 Million
Q1 2020 May 13, 2020	BUY	$41.2 - $101.31 $3.01 Million - $7.41 Million	73,163 New	73,163 $4.3 Million

290

37.1M

401K

464K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.38B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.